High-Potency Cannabis: America’s New Pastime and Psychiatry’s Next Challenge
High-potency cannabis psychiatric risks are increasingly relevant as these products are marketed for mental health conditions despite limited evidence. Clinicians must understand these risks to guide patients effectively. This article highlights the…
Cannabis Europa Returns to London with Patient Issues on the Agenda
Cannabis patient advocacy initiatives are gaining prominence at Cannabis Europa in London. These initiatives emphasize patient-centered approaches to cannabis medicine development. They aim to improve clinical access and address real-world challenges in…
“Canna-Curious”: Legalization and Medical Marijuana | Harvard Independent
Generational attitudes medical cannabis are shifting as younger patients increasingly view cannabis as normalized medicine. This change impacts clinical communication and patient education strategies. Understanding these attitudes helps clinicians…
The Impact of Recreational Cannabis Legalization on Pediatric Emergency Visits
Pediatric cannabis exposure trends have shifted following recreational legalization, impacting emergency department visits. This data informs clinical risk assessments and safety protocols. Understanding these trends is critical for pediatric care in…
Cannabis Sales Plummet as Regulators Crack Down on Booming Industry
Cannabis market disruption is intensifying as regulators crack down on the booming industry. This enforcement affects patient access to therapeutic cannabis and treatment continuity. Clinicians must understand these changes to support patient care…
FDA’s New Enforcement Move on Hemp CBD: What It Means for Patients
FDA hemp product enforcement is reshaping the regulatory landscape for CBD products. This enforcement impacts patient access to quality-controlled hemp CBD products. Clinicians must navigate these changes carefully to advise patients effectively.
Zurich’s Cannabis Trial Extension Highlights Swiss Access Models
Switzerland cannabis access models are evolving with Zurich's cannabis trial extension. This trial demonstrates promising safety and efficacy outcomes. The extension highlights important clinical implications for medical cannabis programs.
Clarifying Discussions on Nevada City Cannabis and Short-Term Rental Ordinances
Municipal cannabis policy changes in Nevada City are shaping patient access to legal cannabis medicine. These local ordinance updates affect compliance requirements and availability for medical users. Understanding these changes is crucial for navigating…
Virginia Lawmakers Push Back on Governor’s Cannabis Amendments (Newsletter: April 15, 2026)
Virginia cannabis regulation updates are creating uncertainty for patient access to medical cannabis. Lawmakers are pushing back on gubernatorial amendments, impacting clinical practice. These regulation updates highlight the need for clinicians to…
Self-reported reasons for medical and nonmedical cannabis use in Australia: A cross-sectional analysis of the International Cannabis Policy Study 2023.
This study highlights dual-use cannabis consumption among Australian adults, showing that many combine medical and nonmedical cannabis. Dual-use cannabis consumption represents a significant portion of users, reflecting real-world use beyond regulatory…